어플

Orion completes acquisition of LegoChem Biosciences

Business / Paul Lee / 04/01/2024 03:57 AM

(Photo = Yonhap news)

 

[Alpha Biz=(Chicago) Reporter Paul Lee] Orion said it has become the largest shareholder after paying 548.5 billion won in stock prices to acquire a 25.73% stake in LegoChem Biosciences.

Orion participated in LegoChem Biosciences's third-party paid-in capital increase and was allocated 7,963,283 shares for 59,000 won. It purchased 1.4 million old shares at a base price of 56,186 won from its founder Kim Yong-joo and CEO Park Se-jin to secure a total of 9,363,283 shares.

It plans to develop new drugs through its affiliate LegoChem Biosciences and complete its business portfolio for the group's sustainable growth.

 

 

 

AlphaBIZ Paul Lee(hoondork1977@alphabiz.co.kr)

Related articles

Dunamu Sanctioned for Misleading Fee Discount Ads Following FIU Violations
Kakao Mobility Denies Allegations of Abuse of Market Dominance in Taxi App Case
Hyosung Heavy Industries, Others Deny Bid-Rigging Charges in KEPCO Tender Case
Samsung Electronics, SK hynix Slide on Google ‘TurboQuant’ Fears, but Analysts See Demand Intact
NH Investment & Securities Cuts LG Chem Target Price on Petrochemical Weakness, Maintains ‘Buy’
comments >

SNS